Company intelligence / Profile preview

G42

Abu Dhabi, Abu Dhabi, United Arab Emirates

Ownership: Private
Development stage: Other

Overview

G42 (now M42 in healthcare) commercializes large-scale genomic, diagnostic, and AI-driven healthcare and research solutions. Has led major clinical initiatives, such as 4Humanity COVID-19 vaccine trials (>43,000 subjects), launched Emirati Genome Program, and operates the region’s largest Omics facility in Abu Dhabi. Recently partnered with Oracle and Cleveland Clinic to launch a global AI-powered healthcare delivery platform; entered deals for pharmaceutical manufacturing with AstraZeneca; and delivers precision medicine and digital health across MENA region and globally.

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: DiagnosticsDigital health platformAI-based solutionsGenome sequencingVaccineSmall molecule
Industry: Molecular Diagnostics

Partnerships

OracleCleveland ClinicAstraZenecaProPhase LabsAmazon Web Services

Beyond the preview

Go deeper on G42.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G42.

Explore the full profile